LitCovid-PubTator  

Documents (50,018) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PubMed 32807241 Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfraction 8.33 KB 2020-08-31 22 116 2021-03-15
PubMed 32442082 Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research. 1. Introduction 7.34 KB 2020-06-04 24 115 2021-03-15
PubMed 32418532 Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SA 5.69 KB 2020-06-04 27 107 2021-03-15
PubMed 32960100 Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. INTRODUCTION: 4.64 KB 2020-11-19 19 100 2021-03-15
PubMed 32610873 Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized p 5.41 KB 2020-09-23 23 86 2021-03-15
PubMed 32744052 IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory eff 4.3 KB 2020-08-18 24 82 2021-03-15
PubMed 32798471 Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a 3.77 KB 2021-05-31 23 80 2021-03-15
PubMed 33213530 Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structure 6.58 KB 2021-01-17 15 78 2021-03-15
PubMed 32736597 PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for p 8.08 KB 2020-08-18 21 77 2021-03-15
PubMed 32938496 Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized pati 5.83 KB 2021-06-04 23 75 2021-03-15